NanoViricides
NNVC
#10138
Rank
โ‚น1.94 B
Marketcap
โ‚น90.23
Share price
2.47%
Change (1 day)
-10.90%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น55.67. an increase over its 2024 EPS that were of -โ‚น63.88.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025-โ‚น57.49-10%
2024-โ‚น63.88-5.41%
2023-โ‚น67.535.71%
2022-โ‚น63.88-13.58%
2021-โ‚น73.92-66.11%
2020-โ‚น218.101.7%
2019-โ‚น214.45-10.98%
2018-โ‚น240.91-22.35%
2017-โ‚น310.27-10.53%
2016-โ‚น346.77375%
2015-โ‚น73.00-85.19%
2014-โ‚น492.7842.11%
2013-โ‚น346.7726.67%
2012-โ‚น273.76-6.25%
2011-โ‚น292.0114.28%
2010-โ‚น255.51100%
2009-โ‚น127.76-0%
2008-โ‚น127.76-33.33%
2007-โ‚น191.64-0%
2006-โ‚น191.644445.07%
2005-โ‚น4.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น594.98-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น692.97-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น271.03-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น328.15-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น193.46-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.56-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA